Why is Onyx Biotec falling/rising?

As of 12-Nov, Onyx Biotec Ltd's stock price is currently at 42.80, reflecting an increase of 0.8, or 1.9%. The stock has shown a strong performance today, outperforming its sector by 0.92%. Additionally, the delivery volume has significantly increased by 1223.53% compared to the 5-day average, indicating rising investor participation. While the stock is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 7.27%, which is notably higher than the Sensex's increase of 1.09%, suggesting a positive momentum in the short term. However, the year-to-date performance shows a decline of 28.07%, contrasting with the Sensex's gain of 9.44%.
In the broader market context, Onyx Biotec's recent rise can be attributed to its strong short-term performance relative to the benchmark, as it has outperformed the Sensex over the past week. Despite this positive movement, the stock's year-to-date decline highlights ongoing challenges that may affect investor sentiment. The significant increase in delivery volume suggests a growing interest among investors, which could be a positive sign for future performance. However, without specific positive or negative factors available, it is difficult to pinpoint the underlying reasons for the stock's fluctuations beyond the observed trading activity and comparative returns.